Recent Finacing
Recent Raise
Armune BioScience develops and commercializes University of Michigan–licensed biomarker diagnostics—including Apifiny, a non‑PSA blood assay—for prostate, lung, and breast cancer, operating research and commercial labs in Ann Arbor.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor